| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/14/2004 | CN1468239A Substituted pyrazoles |
| 01/14/2004 | CN1468238A Substituted pyrazoles |
| 01/14/2004 | CN1468237A Substituted pyrazoles |
| 01/14/2004 | CN1468236A Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 01/14/2004 | CN1468235A Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 01/14/2004 | CN1468233A Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 01/14/2004 | CN1468232A Heterocyclic sodium/proton exchange inhibitors and method |
| 01/14/2004 | CN1468231A Amorphous form of cell cycle inhibitor |
| 01/14/2004 | CN1468230A Chemical compounds |
| 01/14/2004 | CN1468228A 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468226A Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 01/14/2004 | CN1468225A 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 01/14/2004 | CN1468224A Derivatives of quinoline as alpha-2 antagonists |
| 01/14/2004 | CN1468223A Process for producign optically active ethyl (3r,5s,6e)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate |
| 01/14/2004 | CN1468222A N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3 receptor antagonists |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1468220A New piperidine derivatives |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468210A Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 01/14/2004 | CN1468209A Stable salts of o-acetylsalicyclic with basic amino acids |
| 01/14/2004 | CN1468207A New retinoids for the treatment of emphysema |
| 01/14/2004 | CN1468120A Electro-powder |
| 01/14/2004 | CN1468112A The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/14/2004 | CN1468111A A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
| 01/14/2004 | CN1468110A Combinations of statins, estrogenic agents and optionally estrogens |
| 01/14/2004 | CN1468107A Eye drops |
| 01/14/2004 | CN1468104A Use, in combination, of a purine activity and a nonsteroidal anti-inflammatory drug for preparing an anti-thrombotic and/or anti-inflammatory drug |
| 01/14/2004 | CN1468103A Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 01/14/2004 | CN1468102A Modified prodrug forms of ap/amp |
| 01/14/2004 | CN1468101A Method for reducing or stopping smoking |
| 01/14/2004 | CN1468100A Pharmaceutical compositions and methods for use |
| 01/14/2004 | CN1468099A Antitumor therapy comprising distamycin derivatives |
| 01/14/2004 | CN1468098A Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same |
| 01/14/2004 | CN1468097A Compositions comprising modafinil compounds |
| 01/14/2004 | CN1468096A Pharmaceutical solutions of modafinil compounds |
| 01/14/2004 | CN1468094A New pharmaceutical compositions containing epinastine and pseudoephedrine |
| 01/14/2004 | CN1468090A Slow release pharmaceutical preparation and method of administering same |
| 01/14/2004 | CN1468086A Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative |
| 01/14/2004 | CN1468060A Oil/fat composition |
| 01/14/2004 | CN1468059A Oil/fat composition |
| 01/14/2004 | CN1467218A Application of misplaced dichain oligonucleotide in preparing medicines for treating human liver cancer |
| 01/14/2004 | CN1467217A Structure and uses of autisense oligodeoxynucleotide for treating thrombus disease |
| 01/14/2004 | CN1467210A 20-esterifiable camptothecine derivative and method for making same and pharmaceutical combination and uses |
| 01/14/2004 | CN1467207A Method for preparing solid optical pure neutral S- (-) - and (R) - (+) -Omeprazole |
| 01/14/2004 | CN1466996A Human SARS coronary virus receptor inhibitor |
| 01/14/2004 | CN1466994A Compositions and therapeutic use |
| 01/14/2004 | CN1466985A Medicine for treating tummy bug |
| 01/14/2004 | CN1466984A Medicine for treating hepatitis |
| 01/14/2004 | CN1466981A Compound rhizome of Cyrtomium aspirin tablet |
| 01/14/2004 | CN1466978A Chinese traditional medicine for treating cerebral thrombus and method for preparing the same |
| 01/14/2004 | CN1466976A Medicine for preventing and curing rachitis and osteoporosis and method for preparing the same |
| 01/14/2004 | CN1466974A Anti-inflammation antibiotic external used synthesized medicine, soluble hemostatic gauze and method for making the same |
| 01/14/2004 | CN1466972A Effective component preparation of metapanax of araliaceae and method for preparing the same |
| 01/14/2004 | CN1466962A Method for processing aloe gelatin, aloe full-leaf gelatin and aloe skin gelatin |
| 01/14/2004 | CN1466958A Anti-consenescence anti-fatigue health-product containing pure plant extracts |
| 01/14/2004 | CN1466957A Reinforced functional anti-fatigue health-product containing pure plant extracts |
| 01/14/2004 | CN1466952A External preparations for treating dermatitis |
| 01/14/2004 | CN1466951A Gardenoside general extracts preparation and making method and uses |
| 01/14/2004 | CN1466950A Medicine for treating stomach and intestine diseases |
| 01/14/2004 | CN1466949A Medicine composition for reducing blood fat |
| 01/14/2004 | CN1466948A Medicine for getting good sleep |
| 01/14/2004 | CN1466947A Combined medicine containing lamivudine |
| 01/14/2004 | CN1466946A Freeze-drying composition for injection |
| 01/14/2004 | CN1466945A Slow releasing micropill containing active component of indapamide and method for preparing the same |
| 01/14/2004 | CN1466944A Method for preparing nanometer suspension of DHA |
| 01/14/2004 | CN1466943A Use of trans-3,4,5-trihydroxy-diphenyl and derivant for resisting hepatitis B virus |
| 01/14/2004 | CN1466939A Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/14/2004 | CN1134486C Antiviral dendrimers |
| 01/14/2004 | CN1134450C LH-RH peptide analogues, their uses and pharmaceutical compositions containing them |
| 01/14/2004 | CN1134449C Process for preparation of moenomycin A |
| 01/14/2004 | CN1134447C Cefixime tert-octyl ammonium salts , process for preparing the same and method for purification of cefixime |
| 01/14/2004 | CN1134446C Process for preparation of 3-vinylcephem compound |
| 01/14/2004 | CN1134444C Epothilone analog and medicine combination |
| 01/14/2004 | CN1134442C Pyrazolopyrimidinone cGMPPDE 5 inhibitors, method for preparing the same and uses and intermediate |
| 01/14/2004 | CN1134440C 4-oxo-3,5-dihydro-4H-pyridazino [4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy |
| 01/14/2004 | CN1134439C Pyrrolo [2,3D] pyrimidines and their use as tyrosine kinase inhibitors |
| 01/14/2004 | CN1134438C Bicyclic heteroaromatic compounds, method for prepearing the same and uses |
| 01/14/2004 | CN1134437C 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1H)-ketone derivatives |
| 01/14/2004 | CN1134436C Pharmaceutically available protoberberine salt derivatives, and protoberberine derivatives and salt thereof |
| 01/14/2004 | CN1134434C Novel 2-heterocyclically substituted dihydropyrimidines |
| 01/14/2004 | CN1134433C Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 01/14/2004 | CN1134432C Omeprazole sodium salt |
| 01/14/2004 | CN1134431C 2,4-diaminopyrimidine derivatives as dopamine D4 receptor antagonists |
| 01/14/2004 | CN1134430C Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 01/14/2004 | CN1134423C Adhesion receptor antagonists |
| 01/14/2004 | CN1134421C Antifungal and its preparation method and intermediate |
| 01/14/2004 | CN1134420C Novel substituted imidazole compounds |
| 01/14/2004 | CN1134418C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
| 01/14/2004 | CN1134417C 3-phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| 01/14/2004 | CN1134415C Process for making diaryl pyridines useful as cox-2 inhibitors |
| 01/14/2004 | CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 01/14/2004 | CN1134413C Sulfonyl pyrrolidone containing compound and its preparation and pharmaceutical application |
| 01/14/2004 | CN1134412C N-substituted 2-cyanopyrodlidines |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/14/2004 | CN1134405C 5,6-Dihydronaphthalenyl derivatives having retionoid-like activity |
| 01/14/2004 | CN1134266C Methods for inducing T cell tolerance to tissue or organ graft |
| 01/14/2004 | CN1134264C Antithrombotic agents |
| 01/14/2004 | CN1134262C Medicine for treating toothache and method for preparing the same |